Life Science Investment Ltd

QUASIX®

QUASIX® is based on Quassia extract, LSI’s investigators have developed a short cosmetic range especially designed for patients suffering facial redness and rosacea.

 

QUASIX® products are based on a balanced combination of four active ingredients:

 

• Quassia (Quassia amara) vegetal extract, the anti-parasitic, antimicrobial, anti-inflammatory and antioxidant properties of which are widely documented in the scientific literature.

 

• Nicotinamide (Vitamin B3) is capable of maintaining and restoring the integrity of the skin barrier, the natural protector of our epidermis.

 

• Vegetal glycerin is a skin-friendly humectant, which helps to maintain accurate hydration of the upper levels of the epidermis.

• Sorbitol, a sugar which also helps to maintain the correct water balance of the epidermis.

 


Right now, QUASIX® range consists of three products:


QUASIX® Cream, for the management of facial redness and rosacea in dry and mixed skins.


QUASIX® Gel, for the management of facial redness and rosacea in oily skins.


QUASIX® Protective Cream SPF30 is containing a high mineral protector factor, for the special needs of patients with facial redness and rosacea during daytime, in order to protect the skin from harmful UV-rays.



Presentation

Tubes 30g


Origin

Made in Switzerland


www.quasix.eu

CLINICAL EVIDENCES





After 45 days treatment with QUASIX®.

Life Science Investments Ltd. - 50 Sloane Street - SW1X 9SN London - UK   |   © LSI 2015. All Rights Reserved